Using objective measures of physical activity, sleep, and breathing for disease profiling of patients with systemic lupus erythematosus and Sjögren's disease - Scorecard - MDSpire

Login

Using objective measures of physical activity, sleep, and breathing for disease profiling of patients with systemic lupus erythematosus and Sjögren's disease

By
Mehdi Boukhechba
Zhi Li
Elena Reynoso
Ioannis Pandis
Kenneth Mosca
Mark Morris
Stefan Avey
May 29, 2026
0 min

Frontiers In Digital Health

Share

Clinical Scorecard: Employing Objective Assessments of Physical Activity, Sleep Patterns, and Respiratory Function for Disease Characterization in Individuals with Systemic Lupus Erythematosus and Sjögren's Syndrome

At a Glance

Category	Detail
Condition
Key Mechanisms	Remove unsupported claims about key mechanisms unless directly sourced.
Target Population
Care Setting

Key Highlights

highlights

Guideline-Based Recommendations

Diagnosis

E
n
s
u
r
e
r
e
c
o
m
m
e
n
d
a
t
i
o
n
s
a
r
e
a
t
t
r
i
b
u
t
e
d
t
o
t
h
e
s
t
u
d
y
o
r
r
e
l
e
v
a
n
t
g
u
i
d
e
l
i
n
e
s
.

Management

A
d
d
s
o
u
r
c
e
a
t
t
r
i
b
u
t
i
o
n
f
o
r
m
a
n
a
g
e
m
e
n
t
r
e
c
o
m
m
e
n
d
a
t
i
o
n
s
.

Monitoring & Follow-up

I
n
c
l
u
d
e
s
o
u
r
c
e
a
t
t
r
i
b
u
t
i
o
n
f
o
r
m
o
n
i
t
o
r
i
n
g
r
e
c
o
m
m
e
n
d
a
t
i
o
n
s
.

Risks

E
n
s
u
r
e
r
i
s
k
s
a
r
e
d
i
r
e
c
t
l
y
s
o
u
r
c
e
d
f
r
o
m
t
h
e
s
t
u
d
y
.

Patient & Prescribing Data

Clarify insights with specific data from the study.

Clinical Best Practices

best_practices

Related Resources & Content

Original Source(s)

Frontiers In Digital Health

Using objective measures of physical activity, sleep, and breathing for disease profiling of patients with systemic lupus erythematosus and Sjögren's disease

by Mehdi Boukhechba, Zhi Li, Elena Reynoso, Ioannis Pandis, Kenneth Mosca, Mark Morris, Stefan Avey
May 29, 2026

Related Content

Frontiers In Immunology

Plasmacytoid dendritic cells in systemic and cutaneous lupus erythematosus: an evolving understanding

Conexiant

FDA Reshapes Drug Testing Approach

The agency outlined early regulatory actions supporting nonanimal methods, including draft guidance, artificial intelligence tools, and expanded use of human-relevant data models.

by Kathryn Wighton
April 20, 2026
2 min

Conexiant

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

by Kathryn Wighton
April 13, 2026
4 min